0001209191-19-021275.txt : 20190325 0001209191-19-021275.hdr.sgml : 20190325 20190325212353 ACCESSION NUMBER: 0001209191-19-021275 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190323 FILED AS OF DATE: 20190325 DATE AS OF CHANGE: 20190325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOZE BARRY CENTRAL INDEX KEY: 0001619500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 19703954 MAIL ADDRESS: STREET 1: C/O HORIZON PHARMA, INC. STREET 2: 520 EAST COOK ROAD, SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Pharma plc CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-23 0 0001492426 Horizon Pharma plc HZNP 0001619500 MOZE BARRY C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP, Chief Admin. Officer Ordinary Shares 2019-03-23 4 M 0 19250 A 127107 D Ordinary Shares 2019-03-23 4 F 0 8528 26.84 D 118579 D Restricted Stock Units 2019-03-23 4 M 0 19250 0.00 D Ordinary Shares 19250 0 D Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. On March 23, 2015, the reporting person was granted 77,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. /s/ Miles W. McHugh, Attorney-in-Fact 2019-03-25